323 related articles for article (PubMed ID: 35412141)
1. Flavivirus Entry Inhibitors.
Yu Y; Si L; Meng Y
Adv Exp Med Biol; 2022; 1366():171-197. PubMed ID: 35412141
[TBL] [Abstract][Full Text] [Related]
2. Identification of Anti-Premembrane Antibody as a Serocomplex-Specific Marker To Discriminate Zika, Dengue, and West Nile Virus Infections.
Hsieh SC; Tsai WY; Tsai JJ; Stone M; Simmons G; Busch MP; Lanteri M; Stramer SL; Balmaseda A; Harris E; Wang WK
J Virol; 2021 Sep; 95(19):e0061921. PubMed ID: 34232731
[TBL] [Abstract][Full Text] [Related]
3. Human Claudin-Derived Peptides Block the Membrane Fusion Process of Zika Virus and Are Broad Flavivirus Inhibitors.
Zoladek J; Burlaud-Gaillard J; Chazal M; Desgraupes S; Jeannin P; Gessain A; Pardigon N; Hubert M; Roingeard P; Jouvenet N; Afonso PV
Microbiol Spectr; 2022 Oct; 10(5):e0298922. PubMed ID: 36040168
[TBL] [Abstract][Full Text] [Related]
4. Flavivirus proteases: The viral Achilles heel to prevent future pandemics.
Teramoto T; Choi KH; Padmanabhan R
Antiviral Res; 2023 Feb; 210():105516. PubMed ID: 36586467
[TBL] [Abstract][Full Text] [Related]
5. Broad-Spectrum Small-Molecule Inhibitors Targeting the SAM-Binding Site of Flavivirus NS5 Methyltransferase.
Samrat SK; Bashir Q; Huang Y; Trieshmann CW; Tharappel AM; Zhang R; Chen K; Zheng YG; Li Z; Li H
ACS Infect Dis; 2023 Jul; 9(7):1319-1333. PubMed ID: 37348028
[TBL] [Abstract][Full Text] [Related]
6. Flavivirus NS4B protein: Structure, function, and antiviral discovery.
Wang Y; Xie X; Shi PY
Antiviral Res; 2022 Nov; 207():105423. PubMed ID: 36179934
[TBL] [Abstract][Full Text] [Related]
7. Serological evidence of Flavivirus circulation in human populations in Northern Kenya: an assessment of disease risk 2016-2017.
Chepkorir E; Tchouassi DP; Konongoi SL; Lutomiah J; Tigoi C; Irura Z; Eyase F; Venter M; Sang R
Virol J; 2019 May; 16(1):65. PubMed ID: 31101058
[TBL] [Abstract][Full Text] [Related]
8. Lipids and flaviviruses, present and future perspectives for the control of dengue, Zika, and West Nile viruses.
Martín-Acebes MA; Vázquez-Calvo Á; Saiz JC
Prog Lipid Res; 2016 Oct; 64():123-137. PubMed ID: 27702593
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of Flavivirus Neutralizing Antibodies in Thailand by High-Throughput Neutralization Assay: Endemic Circulation of Zika Virus before 2012.
Yamanaka A; Matsuda M; Okabayashi T; Pitaksajjakul P; Ramasoota P; Saito K; Fukasawa M; Hanada K; Matsuura T; Muramatsu M; Shioda T; Suzuki R
mSphere; 2021 Aug; 6(4):e0033921. PubMed ID: 34259560
[TBL] [Abstract][Full Text] [Related]
10. Identification of Estrogen Receptor Modulators as Inhibitors of Flavivirus Infection.
Eyre NS; Kirby EN; Anfiteatro DR; Bracho G; Russo AG; White PA; Aloia AL; Beard MR
Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32482672
[TBL] [Abstract][Full Text] [Related]
11. Establishment of Baculovirus-Expressed VLPs Induced Syncytial Formation Assay for Flavivirus Antiviral Screening.
Dai S; Zhang Y; Zhang T; Zhang B; Wang H; Deng F
Viruses; 2018 Jul; 10(7):. PubMed ID: 29997331
[TBL] [Abstract][Full Text] [Related]
12. Mosquito-Borne Flaviviruses and Current Therapeutic Advances.
Qian X; Qi Z
Viruses; 2022 Jun; 14(6):. PubMed ID: 35746697
[TBL] [Abstract][Full Text] [Related]
13. Identification of the phospholipid binding regions of the envelope E protein of flaviviruses by molecular dynamics.
Carpio LE; Villalaín J
J Biomol Struct Dyn; 2020 Oct; 38(17):5136-5147. PubMed ID: 31779533
[TBL] [Abstract][Full Text] [Related]
14. Zika Virus Subgenomic Flavivirus RNA Generation Requires Cooperativity between Duplicated RNA Structures That Are Essential for Productive Infection in Human Cells.
Pallarés HM; Costa Navarro GS; Villordo SM; Merwaiss F; de Borba L; Gonzalez Lopez Ledesma MM; Ojeda DS; Henrion-Lacritick A; Morales MA; Fabri C; Saleh MC; Gamarnik AV
J Virol; 2020 Aug; 94(18):. PubMed ID: 32581095
[TBL] [Abstract][Full Text] [Related]
15. Methylene blue is a potent and broad-spectrum inhibitor against Zika virus
Li Z; Lang Y; Sakamuru S; Samrat S; Trudeau N; Kuo L; Rugenstein N; Tharappel A; D'Brant L; Koetzner CA; Hu S; Zhang J; Huang R; Kramer LD; Butler D; Xia M; Li H
Emerg Microbes Infect; 2020 Dec; 9(1):2404-2416. PubMed ID: 33078696
[TBL] [Abstract][Full Text] [Related]
16. Recent Advancements in Mosquito-Borne Flavivirus Vaccine Development.
Wu B; Qi Z; Qian X
Viruses; 2023 Mar; 15(4):. PubMed ID: 37112794
[TBL] [Abstract][Full Text] [Related]
17. Structurally Conserved Domains between Flavivirus and Alphavirus Fusion Glycoproteins Contribute to Replication and Infectious-Virion Production.
Rangel MV; Catanzaro N; Thannickal SA; Crotty KA; Noval MG; Johnson KEE; Ghedin E; Lazear HM; Stapleford KA
J Virol; 2022 Jan; 96(2):e0177421. PubMed ID: 34757841
[TBL] [Abstract][Full Text] [Related]
18. Flavivirus Receptors: Diversity, Identity, and Cell Entry.
Laureti M; Narayanan D; Rodriguez-Andres J; Fazakerley JK; Kedzierski L
Front Immunol; 2018; 9():2180. PubMed ID: 30319635
[TBL] [Abstract][Full Text] [Related]
19. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses.
Kampmann T; Yennamalli R; Campbell P; Stoermer MJ; Fairlie DP; Kobe B; Young PR
Antiviral Res; 2009 Dec; 84(3):234-41. PubMed ID: 19781577
[TBL] [Abstract][Full Text] [Related]
20. Phospholipid binding of the dengue virus envelope E protein segment containing the conserved His residue.
Villalaín J
Biochim Biophys Acta Biomembr; 2023 Oct; 1865(7):184198. PubMed ID: 37437754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
